Skip to content

Microbot Medical MBOT Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

AngioDynamics logo
AngioDynamicsANGO
Novanta logo
NovantaNOVT

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's interest income (expense), nonoperating?
Microbot Medical (MBOT) reported interest income (expense), nonoperating of $649K in Q1 2026.
How has Microbot Medical's interest income (expense), nonoperating changed year-over-year?
Microbot Medical's interest income (expense), nonoperating increased by 524.0% year-over-year, from $104K to $649K.
What is the long-term trend for Microbot Medical's interest income (expense), nonoperating?
Over 4 years (2021 to 2025), Microbot Medical's interest income (expense), nonoperating has grown at a 132.5% compound annual growth rate (CAGR), from $44K to $1.29M.